Annual Meeting Archives
2016
Category:
Oral Delivery
Institutions:
(1) Samsung Fine Chemicals, Korea
Category:
an innovative alternative for treatment of schizophrenia
Institutions:
F. DORKOOSH (1), A. Hedayati (1), P. Dehghankelishadi (2), N. Bahari Javan (1)
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Institutions:
(1) Akina, Inc., U.S.A.; (2) FDA CDER, U.S.A.; (3) FDA, U.S.A.
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Institutions:
(1) Oregon State University/Oregon Health and Science University College of Pharmacy, U.S.A.
Category:
Local Drug Delivery
Institutions:
(1) Faculty of Pharmacy, Australia; (2) Diseases and Immunology, Sydney Medical School, The University of Sydney, Australia; (3) University of Sydney, Australia
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Institutions:
(1) FDA, U.S.A.
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Icahn School of Medicine at Mount Sinai, U.S.A.; (2) Norwegian University of Science and Technology, Norway
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Institutions:
(1) Sungkyunkwan University, South Korea
Category:
Transdermal Delivery
Institutions:
(1) Appalachian College of Pharmacy, U.S.A.; (2) Alexandria University, Egypt
Category:
New Processes, New Materials, New Products
Institutions:
(1) University of Washington, U.S.A.
Category:
Delivery Technologies in Cosmetics, Personal Care, and Household Products
Institutions:
(1) The University of Edinburgh, United Kingdom
Category:
Oral Delivery
Institutions:
(1) Shin-Etsu Chemical, U.S.A.; (2) Shin-Etsu Chemical, Japan
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) Department of Micro- and Nanotechnology, DTU Nanotech, Technical University of Denmark, Denmark; (2) Department of Chemistry, DTU Chemistry, Technical University of Denmark, Denmark
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, 9000 Ghent, Belgium
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Imperial College London, United Kingdom
Category:
Transdermal Delivery
Institutions:
(1) UNC at Chapel Hill / NC State, U.S.A.
Category:
Comparative Pharmacokinetics in Preclinical Sciences
Institutions:
(1) School of Pharmaceutical Sciences, São Paulo State Universit “Júlio de Mesquita Filho”, Brazil; (2) Center for Molecular Recognition and Technological Development, Universit of Valencia, Spain
Category:
Oral Delivery
Institutions:
(1) Princess Nourah Bint Abdelrahman University, Saudi Arabia; (2) Department of Pharmaceutics, College of Pharmacy, King Saud University, Saudi Arabia; (3) Newcastle University, United Kingdom
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) Faculty of pharmacy, Ain Shams university, Egypt
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) National Tsing Hua University, Taiwan
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) FU Berlin, Germany; (2) Dendropharm, Germany
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) UT Southwestern Medical Center, U.S.A.
Category:
New Processes, New Materials, New Products
Institutions:
(1) National University of Singapore, Singapore; (2) Institute of Bioengineering and Nanotechnology, Singapore; (3) Department of Pharmacy, NUS, Singapore
Category:
Comparative Pharmacokinetics in Preclinical Sciences
Institutions:
(1) Sichuan University, China
Category:
Comparative Pharmacokinetics in Preclinical Sciences
Institutions:
(1) University of Nebraska Medical Center, U.S.A.